DUBLIN–(BUSINESS WIRE)–The “Bioinformatics: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.
The high growth rate of bioinformatics is attributed to factors such as the demand for antibodies research, the expanding COVID-19 pandemic, epidemics of other infectious diseases, and an increase in R&D activities by key companies to develop new data regarding genetic consequences to counter the rise in different infectious diseases globally. Moreover, the advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies and the usage of different bioinformatic tools.
For example, publicly available datasets of human BCR were selected to represent different sequencing platforms such as Illumina MiSeq, Roche 454, and Ion Torrent. Sample preparation protocols, data quality and disease status information are also required during sequencing. The use of different tools manufactured by key players is likely to propel the growth of the bioinformatics market during the forecast period.
Genomics continues to attract significant investment from public and private funds, which has fueled the development of subdisciplines such as chemogenomics, metagenomics, pharmacogenomics and toxicogenomics. Further advances in high-throughput technologies have led to a decline in sequencing costs and an increase in data generation. The rapid evolution of cloud-based solutions has helped address some IT infrastructure issues relating to data storage and retrieval, although challenges remain with respect to data security.
Proteomics is increasingly gaining pace and offers considerable potential, particularly to the pharma industry, as the vast number of approved drugs act directly on protein targets, and the development of biologics and orphan drugs is high on pharma radar. For instance, according to the Journal of Proteome Research, the Human Proteome Organization (HUPO) has a working group, the Proteomics Standards Initiative (PSI), whose mission is to define data standards for proteomics. HUPO is also exploring the application of proteomics for the purpose of integrating it with genomics and transcriptomics across the life sciences and biomedical research. Advances in proteomics and the interpretation of multiplexed proteomics data will continue to attract investment from the industry.
The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.
By solution, hardware application, sequencing services and platform, end user, and geography, the market has been segmented into the North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. Detailed analysis of major countries such as the U.S., Germany, the UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and Australia will be covered in each country’s respective regional segment. In the market valuations, 2022 serves as the base year, while estimated values are provided for 2023 and forecast values for 2028.
Key Market Dynamics
Market Drivers
- New Discoveries in Biological Sciences
- Increasing Use of Bioinformatics Analytical Software
- New Antibody Technologies and Antibody Types
- Antibody-Based Drug Discovery and Development
- Developed and Increasing Research Areas
- Increased Government Funding in Emerging Markets
- Need for Further Human Genomic and Proteomic Research
- New Application-Focused Technology Platforms
Market Restraints
- Challenging Issues with Modeling Systems
- Ethical Concerns with Bioinformatics and Computational Genomics
Market Opportunities
- Market Expansion into Emerging Countries
- Development of Novel Bioinformatics and Drugs
The Report Includes
- 123 data tables and 90 additional tables
- An up-to-date overview and industry analysis of the global bioinformatics market
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimation of the market size and revenue forecast for the global bioinformatics market, and corresponding market share analysis based on solution, hardware type, application, sequencing services and platforms, end use, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
- Coverage of information on the latest developments in the bioinformatics tools and services market, innovations in bioinformatics solutions for drug discovery, and details of antibody-based drug discovery and developments
- Impact analysis of various region specific and industry specific macroeconomic variables on global bioinformatics market
- Identification of the innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
- Understanding of the importance of ESG in the market for bioinformatics tools and services, consumer attitudes towards sustainability, risks & opportunity assessment, ratings and matrices, and ESG practices in global bioinformatics marketplace
- A look at the major vendors in the global bioinformatics market, and analyze the structure of this industry with respect to company market shares, venture fundings, and recent M&A activities
- Patent analysis covering significant allotments of recent patent grants across each major category
- Profile descriptions of the leading market players
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
- Biological Data Sources
- Bioinformatics in Systems Biology
- Bioinformatics in Precision Medicine
- Bioinformatics in Drug Development
- Cheminformatics
- Next-Generation Sequencing
- Bioinformatics in Metagenomics
- Bioinformatics in Database Management Systems
- Market Trends
- Precision Medicine and Biomarker Identification
- Cloud-Based Solutions
- Shift Toward Value-Based Care
- Rise of ChatGPT
- Market Challenges
- Data Integration
- Data Reliability and Standardization
- End-to-End Workflows
- Market Trends in Bioinformatics Tools and Software
- Purchasing Factors Analysis
- Analyzing Experimental Data
Chapter 4 Market Dynamics
Chapter 5 Market Breakdown by Application
Chapter 6 Market for Sequencing Services and Platforms
Chapter 7 Market Breakdown by Solution
Chapter 8 Market Breakdown by End Use
Chapter 9 Market Breakdown by Region
Chapter 10 ESG Development
Chapter 11 Bioinformatics Applications in Pharmaceutical R&D
Chapter 12 Emerging Technologies and Developments
- Data Science: The Era of New Technology
- Soft Computing Approach
- Challenges and Future Research Direction
Chapter 13 Qualitative Information on New Software
- FastFinder
- WorkFlow Language
- Seven Bridges Platform
Chapter 14 M&A and Venture Funding Outlook
- M&A Analysis
- Research Grants
- Public Funding
- Private Funding
Chapter 15 Competitive Intelligence
Chapter 16 Company Profiles
- 3Rd Millennium
- Agilent Technologies
- Bio-Rad
- Bio-Techne
- Compugen
- Dassault Systemes Biovia
- Dnastar
- Genedata
- Illumina
- Inte:Ligand Software
- Macvector
- Molecular Connections
- Molecular Networks
- Nonlinear Dynamics
- Ocimum Biosolutions
- Perkinelmer Informatics
- Personalis
- Qlucore
- Real Time Genomics
- Smartgene Services
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/w8nzov
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900